Sudden cardiac death (SCD) is the most common mode of death in childhood hypertrophic cardiomyopathy (HCM). The newly developed HCM Risk-Kids model provides clinicians with individualized estimates of risk. The aim of this study was to externally validate the model in a large independent, multi-centre patient cohort.
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy / Norrish, G., Qu, C., Field, E., Cervi, E., Khraiche, D., Klaassen, S., Ojala, T.H., Sinagra, G., Yamazawa, H., Marrone, C., Popoiu, A., Centeno, F., Schouvey, S., Olivotto, I., Day, S.M., Colan, S., Rossano, J., Wittekind, S.G., Saberi, S., Russell, M., et al.. - In: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. - ISSN 2047-4873. - 29:4(2022), pp. 678-686. [10.1093/eurjpc/zwab181]
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
Sinagra, Gianfranco;
2022-01-01
Abstract
Sudden cardiac death (SCD) is the most common mode of death in childhood hypertrophic cardiomyopathy (HCM). The newly developed HCM Risk-Kids model provides clinicians with individualized estimates of risk. The aim of this study was to externally validate the model in a large independent, multi-centre patient cohort.| File | Dimensione | Formato | |
|---|---|---|---|
|
zwab181.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
562.67 kB
Formato
Adobe PDF
|
562.67 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
